World's Best Scientists 2026 revealed!
Gerald Friedland

Gerald Friedland

D-Index & Metrics

Medicine

D-Index
91
Citations
40685
World Ranking
11578
National Ranking
5941

Overview

Gerald Friedland is affiliated with Yale University in the United States. Their research primarily focuses on medicine, with a substantial body of work in infectious diseases. They have contributed to 43 publications in this field, covering various subfields including infectious diseases, epidemiology, artificial intelligence, general health professions, and sociology and political science.

The scientist's main topics of study span several aspects of infectious diseases and public health:

  • HIV/AIDS Research and Interventions
  • Tuberculosis Research and Epidemiology
  • HIV, Drug Use, Sexual Risk
  • Pneumocystis jirovecii pneumonia detection and treatment
  • HIV/AIDS drug development and treatment
  • Telemedicine and Telehealth Implementation
  • Viral Infections and Outbreaks Research

Friedland has published frequently in the following scientific venues:

  • arXiv (Cornell University)
  • AIDS and Behavior
  • Clinical Infectious Diseases
  • Open Forum Infectious Diseases
  • The International Journal of Tuberculosis and Lung Disease

Their recent papers include:

  • Experiences with Telemedicine for HIV Care During the COVID-19 Pandemic: A Mixed-Methods Study, 2022, AIDS and Behavior
  • Dynamic needs and challenges of people with drug-resistant tuberculosis and HIV in South Africa: a qualitative study, 2021, The Lancet Global Health
  • Confronting Another Pandemic: Lessons from HIV can Inform Our COVID-19 Response, 2020, AIDS and Behavior
  • Qualitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV, 2021, HIV Medicine
  • Electronic Dose Monitoring Identifies a High-Risk Subpopulation in the Treatment of Drug-resistant Tuberculosis and Human Immunodeficiency Virus, 2020, Clinical Infectious Diseases

Frequent co-authors collaborating with Friedland include:

  • Lydia Barakat
  • K. Rivet Amico
  • Amrita Daftary
  • Jennifer Zelnick
  • Boitumelo Seepamore

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

    Neel R Gandhi;Neel R Gandhi;Anthony Moll;A Willem Sturm;Robert Pawinski

  • A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection

    Peter A. Selwyn;Diana Hartel;Victor A. Lewis;Ellie E. Schoenbaum

  • YFCC100M: the new data in multimedia research

    Bart Thomee;David A. Shamma;Gerald Friedland;Benjamin Elizalde

  • Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome.

    Robert S. Klein;Carol A. Harris;Catherine Butkus Small;Bernice Moll

  • Infective Endocarditis: An Analysis Based on Strict Case Definitions

    C. Fordham Von Reyn;Barry S. Levy;Robert D. Arbeit;Gerald Friedland

  • Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy

    Salim S. Abdool Karim;Kogieleum Naidoo;Anneke Grobler;Nesri Padayatchi

  • Transmission of the human immunodeficiency virus.

    Gerald H. Friedland;Robert S. Klein

  • Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis

    Evan W Orenstein;Sanjay Basu;N Sarita Shah;Jason R Andrews

  • Risk factors for human immunodeficiency virus infection in intravenous drug users

    E E Schoenbaum;D Hartel;P A Selwyn;R S Klein

  • Public health implications of antiretroviral therapy and HIV drug resistance.

    Mark A. Wainberg;Gerald Friedland

  • Acquired immunodeficiency syndrome. Ophthalmic manifestations in ambulatory patients.

    Paul R. Rosenberg;Alan E. Uliss;Gerald H. Friedland;Carol A. Harris

  • The Consistency of Adherence to Antiretroviral Therapy Predicts Biologic Outcomes for Human Immunodeficiency Virus—Infected Persons in Clinical Trials

    Sharon Mannheimer;Gerald Friedland;John Matts;Carroll Child

  • Integration of antiretroviral therapy with tuberculosis treatment

    Salim Safurdeen. Abdool Karim;Kogieleum. Naidoo;Anna Christina. Grobler;Nesri. Padayatchi

  • Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.

    Frederick L Altice;Frederick L Altice;Adeeba Kamarulzaman;Vincent V Soriano;Mauro Schechter

  • Trust and the acceptance of and adherence to antiretroviral therapy.

    Frederick L. Altice;Farzad Mostashari;Gerald H. Friedland

  • An outbreak of type 4b Listeria monocytogenes infection involving patients from eight Boston hospitals

    John L. Ho;Kathryn N. Shands;Gerald Friedland;Paul Eckind

  • Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence.

    S B Mannheimer;J Matts;E Telzak;M Chesney

  • Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome.

    Carol Harris;Catherine Butkus Small;Robert S. Klein;Gerald H. Friedland

  • Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis

    Gerald H. Friedland;Gerald H. Friedland;Brian R. Saltzman;Brian R. Saltzman;Martha F. Rogers;Martha F. Rogers;Patricia A. Kahl;Patricia A. Kahl

Frequent Co-Authors

Raúl Rojas
Raúl Rojas Freie Universität Berlin
Frederick L. Altice
Frederick L. Altice Yale University
Robert S. Klein
Robert S. Klein Icahn School of Medicine at Mount Sinai
Oriol Vinyals
Oriol Vinyals DeepMind (United Kingdom)
Robert S. Klein
Robert S. Klein Washington University in St. Louis
Martha Larson
Martha Larson Radboud University
Jeffrey D. Fisher
Jeffrey D. Fisher University of Connecticut
K. Rivet Amico
K. Rivet Amico University of Michigan–Ann Arbor
Salim S. Abdool Karim
Salim S. Abdool Karim Centre for the AIDS Programme of Research in South Africa
Kannan Ramchandran
Kannan Ramchandran University of California, Berkeley

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While pursuing a traditional medical degree in the USA is a rewarding path, there are several alternative and complementary healthcare careers to consider. For those interested in administrative roles, medical billing and coding schools online offer flexible programs that provide essential skills for working with health records and insurance claims.

If you're passionate about patient care but want a streamlined entry into nursing, you might explore nursing schools that don't require teas test. These programs remove common barriers and simplify the application process.

For those seeking to fast-track their healthcare education, consider accelerated healthcare programs. These options allow you to start your career sooner, often by condensing coursework into a shorter time frame without sacrificing educational quality.

Additionally, registered nurses wishing to advance their qualifications can benefit from adn to msn bridge programs, designed to help working nurses earn a master's degree efficiently and online.

Best Scientists Citing Gerald Friedland

Trending Scientists

Recently Published Articles